Search results - 5 results
Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.
+/6+ PCR, with a genotyping readout as an alternative for the more established enzyme immunoassay (EIA) detection of 14 targeted high-risk human papillomavirus (HPV) types. LMNX is additionally provided ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
attributable fraction and type distribution of human papillomavirus (HPV) in head and neck squamous cell carcinomas by doing a systematic review and meta-analysis. METHODS We did a literature search on PubMed to ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Xu,L; Cindy Simoens; Martin-Hirsch, Pierre Pl; Bryant, Andrew; Beutels, Philippe; Paraskevaidis, Evangelos; van Hoof, Elke; Steben, Marc; Qiao, Youlin; Zhao, Fang-Hui; Schneider, Achim; ...
Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.
indicate increased exposure to human papillomavirus infection and absence of effective screening programs. Rising trends of cervical cancer in the most affected EU member states reveal a worrying pattern ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
Adult Belgium Carcinoma, Squamous Cell Child Female Guideline Adherence HEALTH POLICY Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Humans Insurance, Health, Reimbursement ...